This finding is consistent with former observations, including ours, on the impact of genetic variations of the CTLA-4 gene involved in lower CTLA-4 protein expression with increasing susceptibility to MM development [25,26,27]. This evidence concerns the gene CTLA4 and Miyoshi myopathy.